PFE

2025Q4BMO

Pfizer Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2026-02-03 · Fiscal end 2025-12-31 · Features as of 2026-02-02

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS0.57
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move1.4%
IV front—
P/C full—
P/C front—
Features as of2026-02-02

Run-up

Close—
Ret 5d+3.0%
Ret 10d+3.9%
Ret 20d+5.9%
Ret 30d+6.5%

Post-Earnings Data

Results & reaction

Print

Actual EPS
0.66Beat
Estimated EPS0.57
Actual revenue
17.6B
Surprise %+15.8%
Beat / missBeat
Beat streak 44
Beat streak 88

Reaction

1-day stock reaction+1.6%
Implied vs actual

Implied 1.4%Actual 4.9%

Gap reaction-4.9%
Day result-3.3%
Next-day upYes
Realized / IV3.41×

Post tape

Post 5d+7.1%
Post 10d+6.2%
Post volume91.4M
Vol ×10d1.82×
Vol ×20d1.83×
Post range3.3%